Exhibit 107
Calculation of Filing Fee Table
Form S-8
(Form Type)
Oramed Pharmaceuticals Inc.
(Exact Name of Registrant as Specified in its Charter)
Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Share | Proposed Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||||
Fees to Be Paid | Equity | Common stock, par value $0.012 per share, to be issued under the Oramed Pharmaceuticals Inc. Amended and Restated 2019 Stock Incentive Plan | Rule 457(c) and Rule 457(h) | 4,500,000 | (2) | $ | 4.67 | (3) | $ | 21,015,000 | $ | 0.0000927 | $ | 1,949 | ||||||||||||
Total Offering Amounts | $ | 21,015,000 | $ | 1,949 | ||||||||||||||||||||||
Total Fees Previously Paid | - | |||||||||||||||||||||||||
Total Fee Offsets | - | |||||||||||||||||||||||||
Net Fee Due | $ | 1,949 |
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, or the Securities Act, this registration statement also covers an indeterminate number of additional shares of common stock that may be issued under the Amended and Restated 2019 Stock Incentive Plan to prevent dilution resulting from a share split, reverse share split, stock dividend, combination or reclassification of the common stock, or any other increase or decrease in the number of issued shares of common stock effected without receipt of consideration by the registrant. |
(2) | Represents common stock issuable upon exercise of awards granted under the Oramed Pharmaceuticals Inc. Amended and Restated 2019 Stock Incentive Plan, as amended from time to time. |
(3) | Estimated solely for the purpose of calculating the registration fee in accordance with Rules 457(c) and (h) under the Securities Act, based upon the average of the high $4.88 and low $4.46 prices of the common stock, as reported on the as reported on the Nasdaq Capital Market on July 5, 2022. |